The metabolic syndrome and schizophrenia: a review (Q36272501)

13 August 2017

1 reference

title

The metabolic syndrome and schizophrenia: a review (English)

1 reference

13 August 2017

0 references

1 reference

Jonathan Meyer

1

1 reference

13 August 2017

Carol E Koro

series ordinal

2

1 reference

13 August 2017

Gilbert J L'Italien

series ordinal

3

1 reference

13 August 2017

publication date

1 June 2005

1 reference

International Review of Psychiatry

13 August 2017

published in

1 reference

13 August 2017

volume

17

1 reference

13 August 2017

issue

3

1 reference

13 August 2017

page(s)

173-180

1 reference

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09540260500071798

The prevalence of the metabolic syndrome in patients with schizoaffective disorder--bipolar subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500071798

Cardiovascular risk factors for people with mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500071798

Prevalence and correlates of diabetes in national schizophrenia samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500071798

Effect of acute metabolic stress on pituitary-adrenal axis activation in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500071798

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500071798

A comparison of the prevalence of the metabolic syndrome using two proposed definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500071798

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500071798

Insulin resistance: the fundamental trigger of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500071798

Increased suicide attempt rate among patients interrupting use of atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500071798

Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500071798

Physical health monitoring of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500071798

Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500071798

The effects of antipsychotic therapy on serum lipids: a comprehensive review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500071798

A review of the effect of atypical antipsychotics on weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500071798

Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500071798

Mortality and causes of death in schizophrenia in Stockholm county, Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500071798

The glucocorticoid receptor gene and its association to metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500071798

Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500071798

The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500071798

Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500071798

Steroid metabolism in metabolic syndrome X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500071798

Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500071798

10.1080/09540260500071798

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference